Open AccessAddition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study
Author(s) -
N. P. Polyzos,
Michel De Vos,
Roberta Corona,
Veerle Vloeberghs,
Carolina OrtegaHrepich,
Dominic Stoop,
Herman Tournaye
Publication year - 2013
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/det045
Subject(s) - antagonist , medicine , poor responder , gynecology , hmg coa reductase , andrology , pharmacology , chemistry , receptor , biochemistry , reductase , enzyme
Will sequential administration of highly purified (hp)-HMG after corifollitropin alfa in a GnRH antagonist protocol benefit women with poor ovarian response according to the Bologna criteria?
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom